Literature DB >> 23426183

Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.

Sichuan Xi1, Hong Xu, Jigui Shan, Yongguang Tao, Julie A Hong, Suzanne Inchauste, Mary Zhang, Tricia F Kunst, Leandro Mercedes, David S Schrump.   

Abstract

MicroRNAs are critical mediators of stem cell pluripotency, differentiation, and malignancy. Limited information exists regarding microRNA alterations that facilitate initiation and progression of human lung cancers. In this study, array techniques were used to evaluate microRNA expression in normal human respiratory epithelia and lung cancer cells cultured in the presence or absence of cigarette smoke condensate (CSC). Under relevant exposure conditions, CSC significantly repressed miR-487b. Subsequent experiments demonstrated that miR-487b directly targeted SUZ12, BMI1, WNT5A, MYC, and KRAS. Repression of miR-487b correlated with overexpression of these targets in primary lung cancers and coincided with DNA methylation, de novo nucleosome occupancy, and decreased H2AZ and TCF1 levels within the miR-487b genomic locus. Deoxy-azacytidine derepressed miR-487b and attenuated CSC-mediated silencing of miR-487b. Constitutive expression of miR-487b abrogated Wnt signaling, inhibited in vitro proliferation and invasion of lung cancer cells mediated by CSC or overexpression of miR-487b targets, and decreased growth and metastatic potential of lung cancer cells in vivo. Collectively, these findings indicate that miR-487b is a tumor suppressor microRNA silenced by epigenetic mechanisms during tobacco-induced pulmonary carcinogenesis and suggest that DNA demethylating agents may be useful for activating miR-487b for lung cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426183      PMCID: PMC3582115          DOI: 10.1172/JCI61271

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

Review 1.  Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.

Authors:  Mattia Boeri; Ugo Pastorino; Gabriella Sozzi
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

2.  Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate.

Authors:  F Liu; J K Killian; M Yang; R L Walker; J A Hong; M Zhang; S Davis; Y Zhang; M Hussain; S Xi; M Rao; P A Meltzer; D S Schrump
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

3.  Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.

Authors:  Y Hasegawa; S Takanashi; Y Kanehira; T Tsushima; T Imai; K Okumura
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

4.  H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment.

Authors:  Menno P Creyghton; Styliani Markoulaki; Stuart S Levine; Jacob Hanna; Michael A Lodato; Ky Sha; Richard A Young; Rudolf Jaenisch; Laurie A Boyer
Journal:  Cell       Date:  2008-11-06       Impact factor: 41.582

Review 5.  Epigenetic control of embryonic stem cell fate.

Authors:  Nicolaj Strøyer Christophersen; Kristian Helin
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

6.  Acetylation of H2AZ Lys 14 is associated with genome-wide gene activity in yeast.

Authors:  Catherine B Millar; Feng Xu; Kangling Zhang; Michael Grunstein
Journal:  Genes Dev       Date:  2006-03-15       Impact factor: 11.361

Review 7.  Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells.

Authors:  Jeffrey S Huo; Elias T Zambidis
Journal:  Biochim Biophys Acta       Date:  2012-10-24

8.  Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.

Authors:  C-H Gattolliat; L Thomas; S A Ciafrè; G Meurice; G Le Teuff; B Job; C Richon; V Combaret; P Dessen; D Valteau-Couanet; E May; P Busson; S Douc-Rasy; J Bénard
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

9.  Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data.

Authors:  Chia-Hung Chien; Yi-Ming Sun; Wen-Chi Chang; Pei-Yun Chiang-Hsieh; Tzong-Yi Lee; Wei-Chih Tsai; Jorng-Tzong Horng; Ann-Ping Tsou; Hsien-Da Huang
Journal:  Nucleic Acids Res       Date:  2011-08-05       Impact factor: 16.971

10.  The global burden of cancer: priorities for prevention.

Authors:  Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward
Journal:  Carcinogenesis       Date:  2009-11-24       Impact factor: 4.944

View more
  58 in total

1.  A network map of IL-33 signaling pathway.

Authors:  Sneha M Pinto; Yashwanth Subbannayya; D A B Rex; Rajesh Raju; Oishi Chatterjee; Jayshree Advani; Aneesha Radhakrishnan; T S Keshava Prasad; Mohan R Wani; Akhilesh Pandey
Journal:  J Cell Commun Signal       Date:  2018-04-28       Impact factor: 5.782

Review 2.  The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support.

Authors:  Graham W Warren; Samantha Sobus; Ellen R Gritz
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

3.  Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.

Authors:  Hesham Basma; Yoko Gunji; Shunichiro Iwasawa; Amy Nelson; Maha Farid; Jun Ikari; Xiangde Liu; Xingqi Wang; Joel Michalski; Lynette Smith; Javeed Iqbal; Radwa El Behery; William West; Sowmya Yelamanchili; Deborah Rennard; Olaf Holz; Kai-Christian Mueller; Helgo Magnussen; Klaus Rabe; Peter J Castaldi; Stephen I Rennard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-31       Impact factor: 5.464

4.  Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy.

Authors:  Minal Garg
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

5.  The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer.

Authors:  S M Jamshedur Rahman; Xiangming Ji; Lisa J Zimmerman; Ming Li; Bradford K Harris; Megan D Hoeksema; Irina A Trenary; Yong Zou; Jun Qian; Robbert Jc Slebos; Jennifer Beane; Avrum Spira; Yu Shyr; Rosana Eisenberg; Daniel C Liebler; Jamey D Young; Pierre P Massion
Journal:  JCI Insight       Date:  2016-11-17

6.  miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.

Authors:  Carmen S Tellez; Daniel E Juri; Kieu Do; Maria A Picchi; Teresa Wang; Gang Liu; Avrum Spira; Steven A Belinsky
Journal:  Cancer Res       Date:  2016-06-14       Impact factor: 12.701

Review 7.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

Review 8.  Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.

Authors:  Gurpreet Kaur; Praveen Sharma; Nilambra Dogra; Sandeep Singh
Journal:  Curr Treat Options Oncol       Date:  2018-03-20

Review 9.  Smoking and microRNA dysregulation: a cancerous combination.

Authors:  Navneet Momi; Sukhwinder Kaur; Satyanarayana Rachagani; Apar K Ganti; Surinder K Batra
Journal:  Trends Mol Med       Date:  2013-11-13       Impact factor: 11.951

Review 10.  Epigenetics in non-small cell lung cancer: from basics to therapeutics.

Authors:  Junaid Ansari; Rodney E Shackelford; Hazem El-Osta
Journal:  Transl Lung Cancer Res       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.